Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...

With the Federal Open Market Committee's first meeting of the year this afternoon — followed by earnings from three of the "Magnificent Seven" — there's no shortage of near-term catalysts today. This ...

Learn how to use multi-timeframe analysis to align weekly, daily, and hourly charts for better trade entries, sharper risk ...

Ether risks declining toward the $1,665-$1,725 range in February, according to a confluence of bearish technical and on-chain indicators. ETH breakdown keeps $1,665 downside target in focus. MVRV ...

The price of Ethereum’s native token, Ether (ETH), risks sliding below $2,000 in February as a classic bearish setup plays out. Key takeaways: As of Wednesday, ETH had entered the breakdown stage of ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

Explore stock market trends with charts. Is the market in a holding pattern? Discover potential trading opportunities with analysis on SPY, Nvidia, and Amazon. Republicans clash over the Senate ...

Teradyne, Inc. is a Buy, favoring patient accumulation on dips given symmetrical risk/reward and potential for further upside. Read more on TER stock here.

If you had walked onto a trading floor thirty years ago, you would have heard noise before you saw anything. Phones ringing, ...